Available Until 4/13/2024

Monoclonal Antibodies for Treatment of COVID-19: Managing Patient and Drug Selection in a Variant Environment

ACPE Activity Number: 0204-0000-21-025-H04-P
Release Date: April 13, 2021
Expiration Date: April 13, 2024
Activity Type: Knowledge-based  
CE Credits: 1.0 hour, no partial credit
Activity Fee: Members – Free / Non-Member – Free

 This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview

This activity will provide an overview of the current Emergency Use Authorizations for monoclonal antibodies for treatment of COVID-19 and the impact of the virus variants across the United States. The program will provide both the U.S. Department of Health And Human Services (HHS) perspectives and actions and the experience of a large health system’s assessment of therapies, access and outcomes evaluation program, and areas to consider supporting management of the changing and emerging data.


The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

This activity was planned to meet the educational needs of pharmacy leaders in the United States providing care for COVID-19 patients.

Learning Objectives

  1. Describe the most current Emergency Use Authorizations for monoclonal antibodies for treatment of COVID-19 and the associated distribution processes to obtain product
  2. Describe the U.S. Department of Health And Human Services (HHS) resources to support utilization and access to of monoclonal antibodies for treatment of COVID-19.
  3. Describe the national guidance on treatment options of monoclonal antibodies.
  4. Identify clinical decision points in selecting a monoclonal antibodies for treatment of COVID-19 based on the virus variants across the United States

Schedule of Activities

  • Introduction and Announcements
  • Presentation
  • Questions, Answers, and Discussion


  • Michael Anderson, M.D., M.B.A., FAAP, FCCM, FAARC, Senior Advisor (Ctr), Federal COVID Response, Office of the Assistant Secretary for Preparedness and Response
    U.S. Department Of Health And Human Services (HHS), Washington, DC
  • Katherine Yang, Pharm.D., M.P.H., Health Sciences Clinical Professor, Department of Clinical Pharmacy, School of Pharmacy University of California, San Francisco, CA
  • Moderator: David Chen, M.B.A., R.Ph., Assistant Vice President of Pharmacy Leadership and Planning, ASHP, Bethesda, MD


In accordance with the ACPE's and ACCME's Standards for Commercial Support, anyone in a position to control the content of an educational activity is required to disclose to the accredited provider their relevant financial relationships. In accordance with these Standards, all potential conflicts of interest have been resolved. An individual has a relevant financial relationship if he or she (or spouse/domestic partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.

As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The Standards for Commercial Support do not consider providers of clinical service directly to patients to be commercial interests. The existence or non-existence of relevant financial relationships will be disclosed to the activity audience. All identified conflicts of interest must be resolved prior to the activity.

  • All planners, presenters, reviewers, and ASHP staff report no financial relationships relevant to this activity. 

Methods and CE Requirements

This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.